Trastuzumab Emtansine

Item number	Size	Datasheet	Manual	SDS	Delivery time	Price
BPS-82923-1	1 mg	-	-	-	3 - 15 business days*	1,915.00€
BPS-82923-2	5 mg	-	-	-	3 - 15 business days*	3,587.00€
BPS-82923-3	10 mg	-	-	-	3 - 15 business days*	5,578.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Trastuzumab emtansine (Ado-Trastuzumab emtansine) is an antibody-drug conjugate (ADC) that... more

Close menu

Product information "Trastuzumab Emtansine"

Trastuzumab emtansine (Ado-Trastuzumab emtansine) is an antibody-drug conjugate (ADC) that incorporates the HER2-targeted antitumor properties of trastuzumab with the cytotoxic activity of the microtubule-inhibitory agent DM1 (derivative of maytansine). Trastuzumab emtansine can be used for the research of advanced breast cancer.1,2

Keywords:	Anti-HER2, Anti-CD340, Anti-ERBB2, Anti-MLN 19, Anti-p185erbB2, EC=2.7.10.1, Anti-Proto-oncogene Neu, Anti-Proto-oncogene c-ErbB-2, Anti-Metastatic lymph node gene 19 protein, Anti-Receptor tyrosine-protein kinase erbB-2,
Supplier:	BPS Bioscience
Supplier-Nr:	82923

Properties

Application:	Cancer therapy target studies
Conjugate:	No
Species reactivity:	human
MW:	~148 kD
Format:	Solution

Database Information

CAS :	1018448-65-1\| Matching products
KEGG ID :	K05083 \| Matching products
UniProt ID :	P04626 \| Matching products
Gene ID :	GeneID 2064 \| Matching products

Handling & Safety

Storage:	-80°C (protect from light)
Shipping:	-80°C (International: -80°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

View product citations for antibody 82923 on CiteAb

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Trastuzumab Emtansine"

Write a review